(Q50004449)

23 February 2018

title

Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report. (English)

1 reference

23 February 2018

0 references

1 reference

1

Steve Ahuka-Mundeke

1 reference

23 February 2018

14

J Erin Staples

1 reference

23 February 2018

11

Terri B Hyde

1 reference

23 February 2018

Janeen Laven

8

object named as

Janeen Laven

1 reference

23 February 2018

author name string

Rebecca M Casey

2

1 reference

23 February 2018

Jennifer B Harris

3

1 reference

23 February 2018

Meredith G Dixon

4

1 reference

23 February 2018

Pierre M Nsele

5

1 reference

23 February 2018

Gabriel M Kizito

6

1 reference

23 February 2018

Grace Umutesi

7

1 reference

23 February 2018

Gilson Paluku

9

1 reference

23 February 2018

Abdou S Gueye

10

1 reference

23 February 2018

Guylain K M Sheria

12

1 reference

23 February 2018

Jean-Jacques Muyembe-Tanfum

13

1 reference

23 February 2018

language of work or name

English

0 references

publication date

14 February 2018

1 reference

23 February 2018

The New England Journal of Medicine

published in

1 reference

23 February 2018

Studies on yellow fever vaccine. III--Dose response in volunteers

cites work

1 reference

12 December 2020

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

1 reference

12 December 2020

Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial

1 reference

12 December 2020

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

12 December 2020

Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus

1 reference

12 December 2020

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

1 reference

12 December 2020

Update on progress controlling yellow fever in Africa, 2004-2008

1 reference

12 December 2020

Intradermal vaccination to protect against yellow fever and influenza

1 reference

12 December 2020

Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study

1 reference

12 December 2020

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study

1 reference

12 December 2020

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

1 reference

12 December 2020

Vaccines and vaccination against yellow fever. WHO position paper -- June 2013

1 reference

12 December 2020

Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data

1 reference

12 December 2020

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

1 reference

12 December 2020

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.

1 reference

12 December 2020

Current status and future prospects of yellow fever vaccines

1 reference

12 December 2020

Prevention and Control of Seasonal Influenza with Vaccines

1 reference

12 December 2020

Yellow fever vaccine: WHO position on the use of fractional doses – June 2017

1 reference

12 December 2020

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

1 reference

12 December 2020

Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo

1 reference

12 December 2020

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1710430

1 reference

23 February 2018

PubMed ID

29443626

1 reference

23 February 2018